Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. American CryoStem Corporation
WARNING LETTER
•American CryoStem Corporation•July 26, 2017

American CryoStem Corporation – FDA Warning Letter, Jul 26, 2017

Record Details

On January 3, 2018, the FDA issued a Warning Letter to American CryoStem Corporation following a July 17-26, 2017, inspection. The firm processes adipose tissue into Stromal Vascular Fraction (SVF) and then expands it through cell culture to produce ATCELL?, an autologous product shipped to physicians for various conditions including anoxic brain injury, Parkinson's, ALS, stroke, and multiple sclerosis.

The FDA determined ATCELL? is a human cell, tissue, or cellular or tissue-based product (HCT/P) but fails to meet the minimal manipulation (21 CFR 1271.10(a)(1)) and homologous use (21 CFR 1271.10(a)(2)) criteria. Processing adipose tissue into SVF and subsequent cell expansion are considered more than minimal manipulation, altering original characteristics. The intended uses for various diseases are not homologous to adipose tissue's basic functions. Therefore, ATCELL? is regulated as a drug and biological product, requiring an approved biologics license application (BLA) or an investigational new drug (IND) application, neither of which is in effect.

The inspection also revealed significant deviations from current Good Manufacturing Practice (CGMP) under 21 CFR Parts 210 and 211, posing safety concerns due to potential contamination and quality defects. Deficiencies include: 1.

Company
American CryoStem Corporation
Inspection date
July 26, 2017
Office
Florida District Office
People
  • Elizabeth A. Waltrip (Program Division Director)
  • Randall L. Morris (Compliance Officer)
  • Anthony Dudzinski
View Company Profile

ID · c2a4ee46-a7b5-42d5-ac7a-54b5f001f0cd

Violation Codes10
21 U.S.C. 321(g)21 CFR 1271.3(d)21 CFR 127121 CFR 1271.10(a)21 CFR 1271.10(a)(1)21 CFR 1271.3(f)(1)21 CFR 1271.10(a)(2)21 CFR 1271.15FD&C Act 501(a)(2)(B)21 CFR 210

Full citation text and observation details available on the Dashboard.

Other documents for American CryoStem Corporation
  • 483 - 2024-05-22May 22, 2024
  • 483 - 2017-07-26July 26, 2017

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore American CryoStem Corporation
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.